
Cincinnati Business Courier: Flash therapy for cancer
Clinical trial led by a UC faculty member looks at cancer therapy delivered in less than a second
UC researchers treated their first study patient this week using a new cancer therapy that takes less than one second.
The trial, being hosted at the Cincinnati Children's Hospital Medical Center/UC Health Proton Therapy Center, is looking at what is known as "flash" therapy, a new mode of radiation that can be delivered to a patient in as little as a single session that lasts less than one second. It is up to 100 times faster than traditional radiation therapy, which delivers the same dose over minutes.
The study patient, the first in the world to participate in the clinical trial, was treated this week at the center. Up to 10 patients, whose metastatic cancer has spread to their bones, will participate in the research clinical trial.
John Breneman, MD, a professor emeritus at UC who is medical director of the center, a UC Health radiation oncologist and principal investigator on the study, says the patient's treatment went very well.
“The prior three years of preparation by the researchers, engineers, clinical and physics teams culminated in a treatment that was completed in literally a blink of the eye, and the patient was discharged,” he says.
Read the full Cincinnati Business Courier story. This publication may require a login.
Read coverage at Healthcare Business News.
Read the Cincinnati Children's media release.
Featured photo of the Cincinnati Children's/UC Health Proton Therapy Center taken in 2019 by Colleen Kelley/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Community disadvantage linked to increased motor symptom...
July 24, 2025
Neurology Live highlighted research led by the University of Cincinnati's Emily Hill that found community disadvantage was associated with worse motor symptom severity and motor disability in patients with Parkison disease (PD) and atypical parkinsonisms.
1819 startup builds AI engineer to help developers code
July 23, 2025
Tembo, an AI-first engineering startup based at UC’s 1819 Innovation Hub, recently rolled out a pioneering AI agent to boost software engineering throughput.
Managing outpatient challenges for hypertensive intracerebral...
July 23, 2025
The University of Cincinnati Gardner Neuroscience Institute's Yasmin Aziz, MD, was featured in a MedCentral article discussing the challenges of managing hypertensive intracerebral hemorrhage in outpatient settings.